Q BIOMED INC. (QBIO) Financial Statements
Q BIOMED INC. (QBIO) files with the U.S. Securities and Exchange Commission under CIK 0001596062. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2022
- Revenue
- $284.35 thousand
- Net Income
- -$2.05 million
- Total Assets
- $3.52 million
- Net Cash from Operations
- $1.94 million
Fiscal year ended Nov 30, 2022. Latest periodic SEC filing: Jun 23, 2023. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for QBIO in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History